ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

This adverse event was reported 6649 times

These drugs are most commonly taken by patients reporting ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE:

# Drug Count
0 METHOTREXATE SODIUM 5880
1 LEFLUNOMIDE 5846
2 ADALIMUMAB 5774
3 TOCILIZUMAB 5716
4 METHOTREXATE 5590
5 INFLIXIMAB 5491
6 RITUXIMAB 5469
7 PREDNISONE 5427
8 CERTOLIZUMAB PEGOL 5424
9 SULFASALAZINE 5396
See all common drugs associated with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CAFFEINE CITRATE 870 0.4069
1 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 230 0.3932
2 PSEUDOEPHEDRINE HYDROCHLORIDE 3419 0.3618
3 CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL 103 0.3433
4 PSEUDOEPHEDRINE HCL 3452 0.3317
5 CORTISONE ACETATE 3783 0.3199
6 DESOXIMETASONE 5244 0.2888
7 TRIPROLIDINE HYDROCHLORIDE 37 0.2176
8 HYDROCORTISONE BUTYRATE 382 0.2173
9 DICLOFENAC POTASSIUM TABLETS 1571 0.2046
See all drugs enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antirheumatic Agent [EPC] 5846 0.0568
1 Interleukin-6 Receptor Antagonist [EPC] 5826 0.0450
2 Aminosalicylate [EPC] 5442 0.0424
3 Selective T Cell Costimulation Modulator [EPC] 5267 0.0395
4 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 668 0.0356
5 Interleukin-12 Antagonist [EPC] 3449 0.0348
6 Histamine-1 Receptor Antagonist [EPC] 2492 0.0317
7 Endoglycosidase [EPC] 214 0.0237
8 Vitamin D [EPC] 5382 0.0184
9 CD20-directed Cytolytic Antibody [EPC] 5507 0.0174
See all drug classes enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE